abstract |
The object of the present invention is the compounds of formula (I), their pharmaceutically acceptable salts, enantiomers, diastereoisomers, and racemates, methods for the preparation of the above-mentioned compounds, agents containing them, and Their manufacture and also the use of the above-mentioned compounds in diseases such as cancer. |